Monsanto gives Bayer limited access to its books: sources
- Wall Street ends down as Trump focuses on trade
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- Qualcomm (QCOM) Thrashed as Apple (AAPL) Lawsuit Threatens Licensing Business Model
- McDonald's (MCD) Tops Q4 EPS by 3c
Monsanto is displayed on a screen where the stock is traded on the floor of the New York Stock Exchange. REUTERS/Brendan McDermid
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
FRANKFURT (Reuters) - U.S. seed company Monsanto has given German suitor Bayer AG limited access to its books after turning down a sweetened $64 billion takeover offer last month, two sources familiar with the situation told Reuters.
The parties have not yet signed a non-disclosure agreement, which would allow Bayer to conduct due diligence, but Monsanto is giving the company a limited drip of information, the sources said.
They said Bayer had no appetite to put a deal at risk by going hostile, although talks were "difficult." The sources requested anonymity because they were not authorized to talk about the matter.
Bayer declined to comment about the development.
Monsanto remains in talks with Bayer and other parties about potential strategic transactions, Chief Executive Officer Hugh Grant told investors gathered at a two-day event in St. Louis on Wednesday. He said the company would not comment further on M&A action and the discussions with Bayer during the event.
The seed and agrochemical industry, long dominated by a handful of big companies, has been jolted by several large deals in the past year as low crop prices and belt-tightening by farmers pressured earnings.
Monsanto's rejection last month of Bayer's latest offer put pressure on the German healthcare and chemical group to increase it to at least get access to the company's books.
Monsanto stock was down 1.2 percent at $104.30, well below Bayer's $125-per-share offer, in afternoon New York Stock Exchange trading. Bayer closed down 2.3 percent at 95.65 euros in Frankfurt.
(Writing by Georgina Prodhan; Additional reporting by Karl Plume in Chicago; Editing by Jane Merriman and Lisa Von Ahn)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Expect Google (GOOGL) To Post A Strong Topline Q4 Report - Goldman Sachs
- Mercury Systems (MRCY) Tops Q2 EPS by 2c, Raises Outlook
- Henry Schein (HSIC) Acquires 51% Stake in Tecnew, Entering Brazilian Market
Create E-mail Alert Related CategoriesMergers and Acquisitions, Reuters
Related EntitiesMerriman Curhan Ford, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!